COLON-MD: Colon Cancer Longitudinal Study
Recruiting now
Conditions studied: Colon Cancer
In brief
The goal of this proposal is to identify how the composition of the gut microbiome and diet interact to impact chemotherapy-induced diarrhea incidence and severity.
Key facts
- Study ID
- NCT04751448
- Run by
- Baylor Research Institute
- People needed
- 11
- Starts
- 2021-02-01
- Expected to finish
- 2026-06-01
- Last updated by the study team
- 2026-01-26
Who can join
Age: 18 and older, up to 79. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Colon cancer diagnosis
- Age >18 and < or equal to 79.
- Ability to perform informed consent
- FOLFOX treatment expected
You may not qualify if…
- Not Pregnant
- Does not have Lynch syndrome or FAP diagnosis.
- Inability to perform inform consent
- inability to comply with follow up program
- history of prior colon cancer diagnosis
- previous treatment with antibiotics in the last month.
- previous bowel resection.
Where it is running
- Baylor Research Institute — Temple, Texas, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.